My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ:MLTX)

14.79 +0.72 (+5.12%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MoonLake Immunotherapeutics - Class A Ordinary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 24, 2023

Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.

Via Benzinga

10 Short Squeeze Stocks To Watch: Getty Images, Guardforce AI And 2 Stocks Moving Up Over 1,000 Positions On The Leaderboard ↗

April 24, 2023

Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High short interest and high cost to borrow are among the...

Via Benzinga

MoonLake Immunotherapeutics to host Capital Markets Day in New York and virtually today

April 19, 2023

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

Where MoonLake Stands With Analysts ↗

March 20, 2023

Via Benzinga

FDA Clears MoonLake's Nanobody Study For Arthritis Patients ↗

September 26, 2022

Via Benzinga

10 Short Squeeze Candidates: Getty Images Tops List, PaxMedica Rejoins Top Five, MicroStrategy Moves Up And More ↗

April 10, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2023 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2023 ↗

March 22, 2023

Via Benzinga

Charles Schwab To Rally Over 19%? Here Are 10 Other Analyst Forecasts For Monday ↗

March 20, 2023

HC Wainwright & Co. cut the price target for 89bio, Inc. (NASDAQ: ETNB) from $27 to $25. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. 89bio shares fell 5.2% to trade at $11.80 on...

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 20, 2023

Gainers

Via Benzinga

10 Short Squeeze Candidates: PaxMedica, Blue Apron, MicroStrategy And More ↗

March 20, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...

Via Benzinga

5 Short Squeeze Candidates To Watch: Ambrx Biopharma, Kala Pharmaceuticals And This Company That Moved Up 1,403 Positions ↗

March 13, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023 ↗

March 09, 2023

Via Benzinga

10 Short Squeeze Candidates: China Jo-Jo Drugstores, Expion360, MoonLake, Silvergate And More ↗

March 06, 2023

Via Benzinga

Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path ↗

February 14, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023 ↗

February 14, 2023

Via Benzinga

Top 5 Health Care Stocks That May Collapse In February ↗

February 13, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Singing Machine, Blue Apron, Camber Energy And More Short Squeeze Candidates That Could Soar This Week ↗

December 27, 2022

Potential short squeeze plays gained steam in 2021 and have continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common...

Via Benzinga

Bitcoin Holder MicroStrategy, SurgePays And 3 Other Short Squeeze Stocks That Could Soar This Week ↗

December 12, 2022

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common...

Via Benzinga

PaxMedica, SurgePays, Opal Fuels And More Short Squeeze Candidates That Could Soar This Week ↗

December 05, 2022

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.

Via Benzinga

Getty Images, MoonLake And 3 Other Short Squeeze Candidates That May Soar This Week ↗

November 28, 2022

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.

Via Benzinga

HireRight Holdings, Canoo, VEON And Other Big Gainers From Friday ↗

November 28, 2022

U.S. stocks closed mixed on Friday, with the Dow Jones gaining around 150 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022 ↗

November 11, 2022

Upgrades

Via Benzinga

Marten Transport, Silvergate Capital And Some Other Big Stocks Moving Lower On Tuesday ↗

October 18, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday ↗

September 07, 2022

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.

Via Benzinga

Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session ↗

September 06, 2022

Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist...

Via Benzinga

HC Wainwright Starts Coverage On This 'Best-In-Class Agent For Inflammatory Disorders ↗

July 21, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday ↗

August 16, 2022

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.

Via Benzinga

This Consumer Defensive Stock Is Trading Higher By Around 49%, Here Are 46 Stocks Moving In Friday's Mid-Day Session ↗

July 22, 2022

Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares gained 93% to $10.32. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.

Via Benzinga

This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday ↗

July 22, 2022

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.